Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate. - Wikidata - awgldk - TriplyDB

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

http://www.wikidata.org/entity/Q43236777

about

N-(3-Chloro-1-methyl-1H-indazol-5-yl)-4-methylbenzene-sulfonamide.Ethyl 3-[7-(N-acetyl-4-meth-oxy-benzene-sulfonamido)-3-chloro-2H-indazol-2-yl]propionate N-(2-Allyl-4-eth-oxy-2H-indazol-5-yl)-4-methyl-benzene-sulfonamide.N-(3-Chloro-4-eth-oxy-1-methyl-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide.N-(1-Allyl-3-chloro-4-eth-oxy-1H-indazol-5-yl)-4-methyl-benzene-sulfonamide.4-Meth-oxy-N-(1-methyl-1H-indazol-5-yl)benzene-sulfonamide N-(3-Chloro-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide.N-(1H-Indazol-5-yl)-4-meth-oxy-benzene-sulfonamide.4-Methyl-N-(1-methyl-1H-indazol-5-yl)benzene-sulfonamide.N-(1-Allyl-1H-indazol-5-yl)-4-methyl-benzene-sulfonamide.Crystal structure of N-(1-allyl-3-chloro-4-eth-oxy-1H-indazol-5-yl)-4-meth-oxybenzene-sulfonamide.Crystal structure of N-(1-allyl-3-chloro-1H-indazol-5-yl)-4-methyl-benzene-sulfonamide.1-(4-Methyl-phenyl-sulfon-yl)-5,6-di-nitro-1H-indazole.N-(2-Allyl-4-chloro-2H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide hemi-hydrate.Crystal structure of N-(3-chloro-1-methyl-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide N-(1-Allyl-1H-indazol-5-yl)-4-meth-oxy-benzene-sulfonamide hemihydrate.

P2860

Q38943886-68616308-93A9-4BF9-9BA0-B4985124963B Q38947050-0E86BF7C-6BE3-4EDF-9C86-39B85CB66647 Q39272494-DA383CEF-B0DD-4111-8B6C-AAA08B3DA893 Q40496659-AB63AA8E-EC92-47C8-87E6-1E3C702B462A Q40497313-515165DD-37F9-4324-80DF-9F8407A350C2 Q41814851-7B9689B3-8F2E-4366-9D4B-45A834334867 Q41857497-4132A214-A483-43B0-B8B4-E2F2C83791F4 Q41857635-F70A5008-E407-4837-952C-6CDCB36899D9 Q41857765-00904A56-4572-496D-BA2A-896008E8942F Q41859385-07A6704E-FC4A-49FD-BC63-006FBB5C3A95 Q41860183-F814A88D-8CA2-471C-B536-38E856792ED6 Q41894608-45EEC305-70F6-4297-891E-9CC43742B251 Q41914820-D68B205D-176E-41B1-A681-41A993D19650 Q41914849-C3B4A2CB-B735-429D-807D-07B4C3C586FF Q41915870-DCEFE8E7-1D2B-4A96-877C-52A2B13DC70F Q42089245-B860C7A5-84D3-4068-942D-3A46F22696F4

P2860

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

http://www.wikidata.org/entity/Q43236777

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Ethyl 3-[6-

@nl

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

@en

type

label

Ethyl 3-[6-

@nl

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

@en

prefLabel

Ethyl 3-[6-

@nl

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

@en

P1433

Q43236777-1E431818-E237-4E1E-AC8C-238FDE844A22

P1476

Q43236777-DA887748-EDCC-49F0-9598-E7343FF625B5

P2093

Q43236777-2544C6EA-F016-4B2E-89F6-FC7A81E3F977

Q43236777-5E4E905D-5D47-41D3-940F-EAC05C65F287

Q43236777-7CED1C15-4903-42AF-908E-4F4D0D27B170

Q43236777-B3F1F2D0-E02A-41B3-9C5D-C3CA2897DB0D

Q43236777-C0797DBA-FA40-406C-B760-C1EF65EDDF65

P2860

Q43236777-397F2BFF-1561-43A7-92CC-8AD125F98299

Q43236777-50E94582-570D-48C5-A391-EAD773A6C2B6

Q43236777-59DFD9B1-5F70-492E-BC5D-3A5529B912A2

Q43236777-7B0137F5-FA6B-413C-8550-683B0590AC8C

Q43236777-94B70AC4-E1C1-4ECE-9935-6F346A0A33F1

Q43236777-A6044C99-FA97-4D0A-9D51-6BBB9E7B754E

Q43236777-EE6BC67B-24C2-4010-B176-0134A026FA85

P304

Q43236777-D20A7022-70BB-47E5-9ACF-1E2AB589D6ED

P31

Q43236777-DC55225A-37E2-47AD-9075-A17CB2F132AB

P356

Q43236777-44C0D406-EA36-4D6B-85F8-0CD02B4B2283

P407

Q43236777-94C2B9D2-AD8D-41D9-9D28-BDB24C77E84F

P433

Q43236777-0C84A95C-9047-4B0E-A01E-561E4ECDC300

P478

Q43236777-4D36BCB4-D71B-4546-A42A-74B81E65BAD0

P577

Q43236777-ACF8F5E0-996F-4929-B7E7-A6A5E132E2FC

P5875

Q43236777-449E478C-0306-4C55-BB61-2F3FCCD522BA

P698

Q43236777-A20C66DA-0BED-4DC5-9A08-6A2C148914CC

P932

Q43236777-2089E0DC-EA3C-46CF-A140-09BC915B3E4E

P356

S1600536812051975

P1433

Acta Crystallographica Section E: Structure Reports Online

P1476

Ethyl 3-[6-(4-meth-oxy-benzene-sulfon-amido)-2H-indazol-2-yl]propano-ate monohydrate.

@en

P2093

Abdellah Hannioui

http://www.w3.org/2001/XMLSchema#string

El Mostapha Rakib

http://www.w3.org/2001/XMLSchema#string

Lahcen El Ammari

http://www.w3.org/2001/XMLSchema#string

Mohamed Saadi

http://www.w3.org/2001/XMLSchema#string

Najat Abbassi

http://www.w3.org/2001/XMLSchema#string

P2860

A short history of SHELX

Structure validation in chemical crystallography.

Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.

Synthesis, antiproliferative and apoptotic activities of N-(6(4)-indazolyl)-benzenesulfonamide derivatives as potential anticancer agents.

Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors.

Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.

Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3, 4-thiadiazole-2-sulfonamide derivatives.

P304

o190-1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1107/S1600536812051975

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235670721

http://www.w3.org/2001/XMLSchema#string

P698

23424475

http://www.w3.org/2001/XMLSchema#string

P932

3569252

http://www.w3.org/2001/XMLSchema#string